首页> 外文期刊>Saudi Pharmaceutical Journal >The use of proton pump inhibitors among older adults with intellectual disability: A cross sectional observational study
【24h】

The use of proton pump inhibitors among older adults with intellectual disability: A cross sectional observational study

机译:质子泵抑制剂在智障老年人中的使用:一项横断面观察研究

获取原文
获取外文期刊封面目录资料

摘要

Background Older people with Intellectual Disability (ID) have a high prevalence of gastrointestinal conditions such as Gastro-Oesophageal Reflux Disease (GORD). However, despite this, information about treatment, in particular the use of Proton Pump Inhibitors (PPIs), in this population is sparse and limited. Objective To investigate the prevalence and pattern of PPI use among older people with ID. Method Data on PPI use and key demographics was analysed from Wave 2 (2013/2014) of IDS-TILDA, a nationally representative longitudinal study of 677 participants aged 40?years and above in Ireland. Descriptive statistics, bivariate analyses and binary logistic regression were carried out. Results Just over a quarter, 27.9% (n?=?189), of participants reported use of PPIs, and 53.4% (n?=?101) were female. The largest proportion of PPI users (53.4%) were aged between 50 and 64 yrs. Most of the PPIs were used in maximum doses (66.7%). However only 43.9% of PPI users had an indication for PPI use (GORD, stomach ulcer or/and an NSAID use), and further 13.2% were also taking an antiplatelet agent. Use among those in residential care homes (54.3%) was much higher than for those living independently or with family (7%). PPI use among those who have severe/profound ID was 25% higher than those with mild ID. Information about the length of PPI use was missing for 31.2%, but of those with data, just over half recorded using the PPIs for more than a year. Apart from an indication, the factors associated with PPI use were older ages (≥50?years), severe/profound level of ID. Conclusion PPI use among older people with intellectual disability is prevalent and frequently long term, often without a clear indication. PPI use especially among those with severe/profound ID and those who live in residential care homes, could predispose these individuals to additional comorbidities and in order to avoid inappropriate long term of use regular review is required.
机译:背景知识智障(ID)老年人的胃肠道疾病患病率很高,例如胃食管反流病(GORD)。然而,尽管如此,在该人群中有关治疗的信息,特别是质子泵抑制剂(PPI)的使用仍然很少。目的探讨有ID的老年人中PPI的使用情况和模式。方法根据IDS-TILDA的第2轮(2013/2014年)对PPI使用和主要人口统计数据进行分析,这是一项全国代表性的纵向研究,研究对象是爱尔兰677位40岁及以上的参与者。进行描述性统计,二元分析和二元逻辑回归。结果刚刚超过四分之一的参与者报告了使用PPI的比例为27.9%(n = 189),女性为53.4%(n = 101)。 PPI用户的最大比例(53.4%)年龄在50至64岁之间。大多数PPI以最大剂量使用(66.7%)。但是,只有43.9%的PPI使用者有使用PPI的适应症(GORD,胃溃疡或/和非甾体抗炎药使用),还有13.2%的人还在服用抗血小板药。在养老院中的使用率(54.3%)远高于独立居住或与家人居住的人(7%)。具有严重/深层ID的人中PPI的使用率比具有轻微ID的人高25%。有关PPI使用时间长度的信息丢失了31.2%,但在有数据的数据中,使用PPI记录了一年多的时间仅占一半以上。除适应症外,与使用PPI有关的因素还包括年龄较大(≥50岁),ID的严重/深刻程度。结论在智障老年人中,PPI的使用非常普遍,并且长期使用,常常没有明确的适应症。 PPI的使用,尤其是在那些ID严重/深重的人以及居住在养老院中的人中,可能使这些人易患其他合并症,并且为了避免长期不适当的使用,需要定期检查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号